TreeWAS – Variant ID: rs1264350

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E03.9 Hypothyroidism, unspecified	1.000	0.000	0.000
E05.9 Thyrotoxicosis, unspecified	1.000	0.000	0.000
E05.0 Thyrotoxicosis with diffuse goitre	1.000	0.000	0.000
E10.9 Without complications	1.000	0.000	0.000
E10.3 With ophthalmic complications	1.000	0.000	0.000
M35.0 Sicca syndrome [Sjogren]	1.000	0.000	0.000
E05 Thyrotoxicosis [hyperthyroidism]	1.000	0.000	0.000
E11 Non-insulin-dependent diabetes mellitus	1.000	0.000	0.000
E10 Insulin-dependent diabetes mellitus	1.000	0.000	0.000
R31 Unspecified haematuria	0.000	0.000	1.000
E10-E14 Diabetes mellitus	1.000	0.000	0.000
E00-E07 Disorders of thyroid gland	1.000	0.000	0.000
I70-I79 Diseases of arteries, arterioles and capillaries	1.000	0.000	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	1.000	0.000	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	1.000	0.000	0.000
# Top node	1.000	0.000	0.000
H36.0 Diabetic retinopathy	1.000	0.000	0.000
Chapter IX Diseases of the circulatory system	1.000	0.000	0.000
E03 Other hypothyroidism	1.000	0.000	0.000
H30-H36 Disorders of choroid and retina	1.000	0.000	0.000
Chapter VII Diseases of the eye and adnexa	1.000	0.000	0.000
H36 Retinal disorders in diseases classified elsewhere	1.000	0.000	0.000
D80-D89 Certain disorders involving the immune mechanism	1.000	0.000	0.000
M35 Other systemic involvement of connective tissue	1.000	0.000	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	1.000	0.000	0.000
E14 Unspecified diabetes mellitus	1.000	0.000	0.000
E16 Other disorders of pancreatic internal secretion	1.000	0.000	0.000
Chapter XIII Diseases of the musculoskeletal system and connective tissue	1.000	0.000	0.000
E16.2 Hypoglycaemia, unspecified	0.999	0.001	0.000
K70-K77 Diseases of liver	0.999	0.001	0.000
Chapter I Certain infectious and parasitic diseases	0.999	0.001	0.000
M20-M25 Other joint disorders	0.999	0.001	0.000
E11.9 Without complications	0.999	0.001	0.000
K75 Other inflammatory liver diseases	0.999	0.001	0.000
I77 Other disorders of arteries and arterioles	0.999	0.001	0.000
D60-D64 Aplastic and other anaemias	0.999	0.001	0.000
D86 Sarcoidosis	0.998	0.002	0.000
I73 Other peripheral vascular diseases	0.997	0.003	0.000
Chapter XX External causes of morbidity and mortality	0.997	0.003	0.000
D50-D53 Nutritional anaemias	0.996	0.004	0.000
D86.9 Sarcoidosis, unspecified	0.996	0.004	0.000
D64 Other anaemias	0.996	0.004	0.000
K75.4 Autoimmune hepatitis	0.995	0.005	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.995	0.005	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.995	0.005	0.000
D64.9 Anaemia, unspecified	0.995	0.005	0.000
E11.3 With ophthalmic complications	0.994	0.006	0.000
E14.3 With ophthalmic complications	0.994	0.006	0.000
I77.1 Stricture of artery	0.994	0.006	0.000
E10.1 With ketoacidosis	0.993	0.007	0.000
Chapter X Diseases of the respiratory system	0.993	0.007	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.993	0.007	0.000
B35-B49 Mycoses	0.993	0.007	0.000
I60-I69 Cerebrovascular diseases	0.992	0.008	0.000
E50-E64 Other nutritional deficiencies	0.992	0.008	0.000
I73.9 Peripheral vascular disease, unspecified	0.992	0.008	0.000
J40-J47 Chronic lower respiratory diseases	0.992	0.008	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.991	0.009	0.000
H34 Retinal vascular occlusions	0.991	0.009	0.000
I63 Cerebral infarction	0.990	0.010	0.000
E10.2 With renal complications	0.988	0.012	0.000
Chapter XIV Diseases of the genitourinary system	0.987	0.013	0.000
N00-N08 Glomerular diseases	0.987	0.013	0.000
E20-E35 Disorders of other endocrine glands	0.987	0.013	0.000
N18 Chronic renal failure	0.987	0.013	0.000
N17-N19 Renal failure	0.986	0.014	0.000
J45 Asthma	0.986	0.014	0.000
B37 Candidiasis	0.986	0.014	0.000
E27.1 Primary adrenocortical insufficiency	0.984	0.016	0.000
J45.9 Asthma, unspecified	0.984	0.016	0.000
J44 Other chronic obstructive pulmonary disease	0.984	0.016	0.000
E27 Other disorders of adrenal gland	0.984	0.016	0.000
K75.8 Other specified inflammatory liver diseases	0.983	0.017	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.982	0.018	0.000
H34.8 Other retinal vascular occlusions	0.981	0.019	0.000
H43-H45 Disorders of vitreous body and globe	0.981	0.019	0.000
D50 Iron deficiency anaemia	0.979	0.021	0.000
I74 Arterial embolism and thrombosis	0.978	0.022	0.000
B37.9 Candidiasis, unspecified	0.975	0.025	0.000
L80-L99 Other disorders of the skin and subcutaneous tissue	0.974	0.026	0.000
I77.6 Arteritis, unspecified	0.974	0.026	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.972	0.028	0.000
W00-W19 Falls	0.971	0.029	0.000
K72 Hepatic failure, not elsewhere classified	0.971	0.029	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.971	0.029	0.000
N40 Hyperplasia of prostate	0.000	0.030	0.970
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.969	0.031	0.000
H43 Disorders of vitreous body	0.967	0.033	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.965	0.035	0.000
E53 Deficiency of other B group vitamins	0.964	0.036	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.963	0.037	0.000
C83.3 Large cell (diffuse)	0.962	0.038	0.000
K74 Fibrosis and cirrhosis of liver	0.962	0.038	0.000
N05 Unspecified nephritic syndrome	0.962	0.038	0.000
C85.1 B-cell lymphoma, unspecified	0.962	0.038	0.000
H43.1 Vitreous haemorrhage	0.961	0.039	0.000
E11.5 With peripheral circulatory complications	0.961	0.039	0.000
N18.0 End-stage renal disease	0.958	0.042	0.000
J33.0 Polyp of nasal cavity	0.954	0.046	0.000
K73 Chronic hepatitis, not elsewhere classified	0.954	0.046	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.953	0.047	0.000
J80-J84 Other respiratory diseases principally affecting the interstitium	0.952	0.048	0.000
J33 Nasal polyp	0.952	0.048	0.000
M05-M14 Inflammatory polyarthropathies	0.950	0.050	0.000
W19 Unspecified fall	0.950	0.050	0.000
L50-L54 Urticaria and erythema	0.948	0.052	0.000
L92 Granulomatous disorders of skin and subcutaneous tissue	0.946	0.054	0.000
E06 Thyroiditis	0.946	0.054	0.000
E53.8 Deficiency of other specified B group vitamins	0.945	0.055	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.945	0.055	0.000
N18.3 Chronic kidney disease, stage 3	0.944	0.056	0.000
J30-J39 Other diseases of upper respiratory tract	0.944	0.056	0.000
D69 Purpura and other haemorrhagic conditions	0.944	0.056	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.944	0.056	0.000
L10-L14 Bullous disorders	0.943	0.057	0.000
D51 Vitamin B12 deficiency anaemia	0.943	0.057	0.000
D61 Other aplastic anaemias	0.942	0.058	0.000
J84 Other interstitial pulmonary diseases	0.941	0.059	0.000
D50.9 Iron deficiency anaemia, unspecified	0.941	0.059	0.000
N04 Nephrotic syndrome	0.936	0.064	0.000
I95-I99 Other and unspecified disorders of the circulatory system	0.936	0.064	0.000
E10.4 With neurological complications	0.928	0.072	0.000
Chapter II Neoplasms	0.928	0.072	0.000
Chapter VI Diseases of the nervous system	0.928	0.072	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.927	0.073	0.000
H46-H48 Disorders of optic nerve and visual pathways	0.927	0.073	0.000
I63.8 Other cerebral infarction	0.926	0.074	0.000
K74.6 Other and unspecified cirrhosis of liver	0.924	0.076	0.000
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.924	0.076	0.000
K72.0 Acute and subacute hepatic failure	0.920	0.080	0.000
Chapter XI Diseases of the digestive system	0.916	0.083	0.001
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.916	0.084	0.000
B02 Zoster [herpes zoster]	0.916	0.084	0.000
B15-B19 Viral hepatitis	0.916	0.084	0.000
L13 Other bullous disorders	0.912	0.088	0.000
K76 Other diseases of liver	0.912	0.088	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.911	0.089	0.000
M10 Gout	0.909	0.091	0.000
M35.3 Polymyalgia rheumatica	0.909	0.091	0.000
E55 Vitamin D deficiency	0.908	0.092	0.000
W19.2 School, other institution and public administrative area	0.908	0.092	0.000
D69.6 Thrombocytopenia, unspecified	0.907	0.093	0.000
N05.2 Diffuse membranous glomerulonephritis	0.903	0.097	0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.902	0.098	0.000
E14.9 Without complications	0.897	0.103	0.000
A30-A49 Other bacterial diseases	0.897	0.103	0.000
C81 Hodgkin's disease	0.896	0.104	0.000
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.895	0.105	0.000
I73.0 Raynaud's syndrome	0.894	0.106	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.892	0.108	0.000
D83 Common variable immunodeficiency	0.892	0.108	0.000
E06.3 Autoimmune thyroiditis	0.891	0.109	0.000
L13.0 Dermatitis herpetiformis	0.890	0.110	0.000
G30-G32 Other degenerative diseases of the nervous system	0.889	0.111	0.000
D80 Immunodeficiency with predominantly antibody defects	0.889	0.111	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.888	0.112	0.000
I62 Other nontraumatic intracranial haemorrhage	0.888	0.112	0.000
M86-M90 Other osteopathies	0.887	0.113	0.000
J46 Status asthmaticus	0.887	0.113	0.000
E14.8 With unspecified complications	0.886	0.114	0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.883	0.117	0.000
E70-E90 Metabolic disorders	0.881	0.119	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.881	0.119	0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.881	0.119	0.000
B37.0 Candidal stomatitis	0.881	0.119	0.000
W13 Fall from, out of or through building or structure	0.880	0.120	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.880	0.120	0.000
L20-L30 Dermatitis and eczema	0.879	0.121	0.000
N04.9 Unspecified	0.877	0.123	0.000
D86.0 Sarcoidosis of lung	0.877	0.123	0.000
K76.9 Liver disease, unspecified	0.877	0.123	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.876	0.124	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.872	0.128	0.000
B44 Aspergillosis	0.871	0.129	0.000
B25-B34 Other viral diseases	0.870	0.130	0.000
B37.8 Candidiasis of other sites	0.870	0.130	0.000
L94 Other localised connective tissue disorders	0.870	0.130	0.000
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.869	0.131	0.000
I27 Other pulmonary heart diseases	0.869	0.131	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.868	0.132	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.868	0.132	0.000
C91 Lymphoid leukaemia	0.866	0.134	0.000
D61.9 Aplastic anaemia, unspecified	0.865	0.135	0.000
K72.9 Hepatic failure, unspecified	0.863	0.137	0.000
L52 Erythema nodosum	0.862	0.138	0.000
V20-V29 Motorcycle rider injured in transport accident	0.862	0.138	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.861	0.139	0.000
I98 Other disorders of circulatory system in diseases classified elsewhere	0.861	0.139	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.860	0.140	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.859	0.141	0.000
X20-X29 Contact with venomous animals and plants	0.859	0.141	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.859	0.141	0.000
E89.0 Postprocedural hypothyroidism	0.858	0.142	0.000
N40-N51 Diseases of male genital organs	0.000	0.144	0.855
C84 Peripheral and cutaneous T-cell lymphomas	0.854	0.146	0.000
M10.9 Gout, unspecified	0.854	0.146	0.000
M86 Osteomyelitis	0.853	0.147	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.853	0.147	0.000
A41 Other septicaemia	0.853	0.147	0.000
V01-V09 Pedestrian injured in transport accident	0.851	0.149	0.000
M32 Systemic lupus erythematosus	0.850	0.149	0.000
B02.9 Zoster without complication	0.850	0.150	0.000
E10.5 With peripheral circulatory complications	0.849	0.151	0.000
E55.9 Vitamin D deficiency, unspecified	0.848	0.152	0.000
L28 Lichen simplex chronicus and prurigo	0.848	0.152	0.000
N42 Other disorders of prostate	0.000	0.153	0.847
G81 Hemiplegia	0.846	0.154	0.000
J33.9 Nasal polyp, unspecified	0.844	0.156	0.000
H46 Optic neuritis	0.843	0.157	0.000
E10.8 With unspecified complications	0.843	0.157	0.000
I27.2 Other secondary pulmonary hypertension	0.842	0.158	0.000
J37 Chronic laryngitis and laryngotracheitis	0.840	0.160	0.000
M20.1 Hallux valgus (acquired)	0.000	0.161	0.839
L53 Other erythematous conditions	0.838	0.162	0.000
C88 Malignant immunoproliferative diseases	0.838	0.162	0.000
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.837	0.163	0.000
G81.9 Hemiplegia, unspecified	0.836	0.164	0.000
M07 Psoriatic and enteropathic arthropathies	0.834	0.166	0.000
E11.1 With ketoacidosis	0.834	0.166	0.000
B18 Chronic viral hepatitis	0.830	0.170	0.000
W05 Fall involving wheelchair	0.828	0.171	0.000
E14.2 Withrenal complications	0.828	0.172	0.000
N18.8 Other chronic renal failure	0.827	0.173	0.000
D50.8 Other iron deficiency anaemias	0.826	0.174	0.000
C34 Malignant neoplasm of bronchus and lung	0.826	0.174	0.000
L93 Lupus erythematosus	0.826	0.174	0.000
C92 Myeloid leukaemia	0.825	0.175	0.000
E03.8 Other specified hypothyroidism	0.825	0.175	0.000
M24 Other specific joint derangements	0.824	0.176	0.000
W19.9 Unspecified place	0.821	0.179	0.000
C34.3 Lower lobe, bronchus or lung	0.819	0.181	0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.819	0.181	0.000
L92.0 Granuloma annulare	0.818	0.182	0.000
X10-X19 Contact with heat and hot substances	0.818	0.182	0.000
G35-G37 Demyelinating diseases of the central nervous system	0.817	0.183	0.000
G50-G59 Nerve, nerve root and plexus disorders	0.815	0.185	0.000
L28.0 Lichen simplex chronicus	0.815	0.185	0.000
W13.9 Unspecified place	0.815	0.185	0.000
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.815	0.185	0.000
K70 Alcoholic liver disease	0.814	0.186	0.000
D83.9 Common variable immunodeficiency, unspecified	0.814	0.186	0.000
E11.7 With multiple complications	0.814	0.186	0.000
H34.2 Other retinal artery occlusions	0.811	0.189	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.810	0.190	0.000
N18.1 Chronic kidney disease, stage 1	0.810	0.190	0.000
K73.9 Chronic hepatitis, unspecified	0.810	0.190	0.000
Y42.7 Androgens and anabolic congeners	0.810	0.190	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.809	0.191	0.000
E14.1 With ketoacidosis	0.809	0.191	0.000
L95 Vasculitis limited to skin, not elsewhere classified	0.809	0.191	0.000
C04 Malignant neoplasm of floor of mouth	0.806	0.194	0.000
M10.94 Gout, unspecified (Hand)	0.806	0.194	0.000
G31.8 Other specified degenerative diseases of nervous system	0.806	0.194	0.000
H06.2 Dysthyroid exophthalmos	0.806	0.194	0.000
I69 Sequelae of cerebrovascular disease	0.806	0.194	0.000
D69.4 Other primary thrombocytopenia	0.802	0.198	0.000
J82 Pulmonary eosinophilia, not elsewhere classified	0.801	0.199	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.800	0.200	0.000
K76.6 Portal hypertension	0.800	0.200	0.000
E51 Thiamine deficiency	0.800	0.200	0.000
M60-M63 Disorders of muscles	0.799	0.201	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.799	0.201	0.000
H30 Chorioretinal inflammation	0.799	0.201	0.000
N18.4 Chronic kidney disease, stage 4	0.798	0.202	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.798	0.202	0.000
A41.9 Septicaemia, unspecified	0.797	0.203	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.797	0.203	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.797	0.203	0.000
E10.7 With multiple complications	0.796	0.204	0.000
B25 Cytomegaloviral disease	0.795	0.205	0.000
Y52 Agents primarily affecting the cardiovascular system	0.795	0.205	0.000
G31.0 Circumscribed brain atrophy	0.793	0.207	0.000
H05 Disorders of orbit	0.793	0.207	0.000
N42.8 Other specified disorders of prostate	0.000	0.208	0.792
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.792	0.208	0.000
N18.5 Chronic kidney disease, stage 5	0.792	0.208	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.792	0.208	0.000
M34 Systemic sclerosis	0.791	0.209	0.000
M86.9 Osteomyelitis, unspecified	0.791	0.209	0.000
I97 Postprocedural disorders of circulatory system, not elsewhere classified	0.789	0.211	0.000
N42.1 Congestion and haemorrhage of prostate	0.000	0.211	0.789
B90-B94 Sequelae of infectious and parasitic diseases	0.788	0.212	0.000
E10.0 With coma	0.788	0.212	0.000
E78.2 Mixed hyperlipidaemia	0.787	0.213	0.000
H43.2 Crystalline deposits in vitreous body	0.787	0.213	0.000
N18.9 Chronic renal failure, unspecified	0.786	0.214	0.000
A50-A64 Infections with a predominantly sexual mode of transmission	0.785	0.215	0.000
M33 Dermatopolymyositis	0.785	0.215	0.000
N05.1 Focal and segmental glomerular lesions	0.783	0.217	0.000
B01 Varicella [chickenpox]	0.783	0.217	0.000
L50 Urticaria	0.782	0.218	0.000
E11.6 With other specified complications	0.782	0.218	0.000
I73.1 Thromboangiitis obliterans [Buerger]	0.780	0.220	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.779	0.221	0.000
D69.5 Secondary thrombocytopenia	0.779	0.221	0.000
E31 Polyglandular dysfunction	0.778	0.222	0.000
W19.3 Sports and athletics area	0.778	0.222	0.000
E11.0 With coma	0.777	0.223	0.000
M35.7 Hypermobility syndrome	0.776	0.224	0.000
K90-K93 Other diseases of the digestive system	0.775	0.225	0.000
E14.6 With other specified complications	0.775	0.225	0.000
G35 Multiple sclerosis	0.775	0.225	0.000
D50.1 Sideropenic dysphagia	0.775	0.225	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.774	0.226	0.000
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.773	0.227	0.000
E24 Cushing's syndrome	0.772	0.228	0.000
M10.0 Idiopathic gout	0.771	0.229	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.771	0.229	0.000
I74.8 Embolism and thrombosis of other arteries	0.771	0.229	0.000
C91.1 Chronic lymphocytic leukaemia	0.770	0.230	0.000
N05.8 Other	0.770	0.230	0.000
J84.8 Other specified interstitial pulmonary diseases	0.769	0.231	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.768	0.232	0.000
E10.6 With other specified complications	0.767	0.233	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.766	0.234	0.000
M10.96 Gout, unspecified (Lower leg)	0.766	0.234	0.000
K90 Intestinal malabsorption	0.766	0.234	0.000
I00-I02 Acute rheumatic fever	0.766	0.234	0.000
M15-M19 Arthrosis	0.765	0.235	0.000
J37.0 Chronic laryngitis	0.765	0.235	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.765	0.235	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.764	0.236	0.000
E14.5 With peripheral circulatory complications	0.764	0.236	0.000
M22 Disorders of patella	0.763	0.237	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.763	0.237	0.000
K74.5 Biliary cirrhosis, unspecified	0.762	0.238	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.762	0.238	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.762	0.238	0.000
X23 Contact with hornets, wasps and bees	0.760	0.240	0.000
E13 Other specified diabetes mellitus	0.758	0.242	0.000
I77.9 Disorder of arteries and arterioles, unspecified	0.757	0.243	0.000
L89 Decubitus ulcer	0.757	0.243	0.000
E06.9 Thyroiditis, unspecified	0.757	0.243	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.757	0.243	0.000
D61.1 Drug-induced aplastic anaemia	0.756	0.244	0.000
E21.0 Primary hyperparathyroidism	0.756	0.244	0.000
M06 Other rheumatoid arthritis	0.755	0.245	0.000
A15-A19 Tuberculosis	0.755	0.245	0.000
J33.8 Other polyp of sinus	0.754	0.246	0.000
I10-I15 Hypertensive diseases	0.754	0.246	0.000
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.754	0.246	0.000
I65.2 Occlusion and stenosis of carotid artery	0.754	0.246	0.000
B02.2 Zoster with other nervous system involvement	0.754	0.246	0.000
B00 Herpesviral [herpes simplex] infections	0.753	0.247	0.000
M00-M03 Infectious arthropathies	0.753	0.247	0.000
E07 Other disorders of thyroid	0.751	0.249	0.000
M07.3 Other psoriatic arthropathies	0.751	0.249	0.000
W14 Fall from tree	0.751	0.249	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.750	0.249	0.000
D52 Folate deficiency anaemia	0.750	0.250	0.000
B20-B24 Human immunodeficiency virus [HIV] disease	0.750	0.250	0.000
E11.8 With unspecified complications	0.749	0.251	0.000
B18.2 Chronic viral hepatitis C	0.749	0.251	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.749	0.251	0.000
B07 Viral warts	0.748	0.252	0.000
J41 Simple and mucopurulent chronic bronchitis	0.747	0.253	0.000
B85-B89 Pediculosis, acariasis and other infestations	0.747	0.253	0.000
C81.9 Hodgkin's disease, unspecified	0.747	0.253	0.000
B44.9 Aspergillosis, unspecified	0.747	0.253	0.000
M70-M79 Other soft tissue disorders	0.747	0.253	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.745	0.255	0.000
G51 Facial nerve disorders	0.744	0.256	0.000
C83.0 Small cell (diffuse)	0.744	0.256	0.000
M32.1 Systemic lupus erythematosus with organ or system involvement	0.744	0.256	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.743	0.257	0.000
E16.1 Other hypoglycaemia	0.742	0.258	0.000
C81.1 Nodular sclerosis	0.742	0.258	0.000
Y59 Other and unspecified vaccines and biological substances	0.741	0.259	0.000
N04.2 Diffuse membranous glomerulonephritis	0.741	0.259	0.000
H31 Other disorders of choroid	0.741	0.259	0.000
D61.0 Constitutional aplastic anaemia	0.741	0.259	0.000
D69.2 Other nonthrombocytopenic purpura	0.740	0.260	0.000
M20 Acquired deformities of fingers and toes	0.004	0.260	0.737
D86.1 Sarcoidosis of lymph nodes	0.740	0.260	0.000
H05.2 Exophthalmic conditions	0.739	0.261	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.739	0.261	0.000
L94.2 Calcinosis cutis	0.739	0.261	0.000
D53 Other nutritional anaemias	0.739	0.261	0.000
H43.9 Disorder of vitreous body, unspecified	0.738	0.262	0.000
K74.3 Primary biliary cirrhosis	0.738	0.262	0.000
W03 Other fall on same level due to collision with, or pushing by, another person	0.737	0.263	0.000
X60-X84 Intentional self-harm	0.737	0.263	0.000
C92.0 Acute myeloid leukaemia	0.736	0.264	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.736	0.264	0.000
M72 Fibroblastic disorders	0.736	0.264	0.000
Y65 Other misadventures during surgical and medical care	0.736	0.264	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.735	0.265	0.000
Y66 Nonadministration of surgical and medical care	0.735	0.265	0.000
H34.9 Retinal vascular occlusion, unspecified	0.733	0.266	0.000
C93 Monocytic leukaemia	0.733	0.266	0.000
W01 Fall on same level from slipping, tripping and stumbling	0.733	0.267	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.732	0.268	0.000
X00-X09 Exposure to smoke, fire and flames	0.732	0.268	0.000
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.732	0.268	0.000
N18.2 Chronic kidney disease, stage 2	0.732	0.268	0.000
V40-V49 Car occupant injured in transport accident	0.730	0.270	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.730	0.270	0.000
W19.1 Residential institution	0.729	0.271	0.000
D86.3 Sarcoidosis of skin	0.729	0.271	0.000
E61 Deficiency of other nutrient elements	0.729	0.271	0.000
E20 Hypoparathyroidism	0.729	0.271	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.728	0.272	0.000
V90-V94 Water transport accidents	0.726	0.274	0.000
K90.9 Intestinal malabsorption, unspecified	0.725	0.275	0.000
E89.2 Postprocedural hypoparathyroidism	0.724	0.276	0.000
B25.9 Cytomegaloviral disease, unspecified	0.724	0.276	0.000
M65-M68 Disorders of synovium and tendon	0.724	0.276	0.000
B37.7 Candidal septicaemia	0.723	0.277	0.000
D55-D59 Haemolytic anaemias	0.723	0.277	0.000
B17 Other acute viral hepatitis	0.723	0.277	0.000
D69.9 Haemorrhagic condition, unspecified	0.722	0.278	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.722	0.278	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.721	0.279	0.000
B37.2 Candidiasis of skin and nail	0.721	0.279	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.719	0.281	0.000
I95 Hypotension	0.719	0.281	0.000
L80 Vitiligo	0.718	0.282	0.000
W50-W64 Exposure to animate mechanical forces	0.718	0.282	0.000
I74.5 Embolism and thrombosis of iliac artery	0.718	0.282	0.000
N25-N29 Other disorders of kidney and ureter	0.718	0.282	0.000
E05.5 Thyroid crisis or storm	0.717	0.283	0.000
E05.4 Thyrotoxicosis factitia	0.717	0.283	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.717	0.283	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.717	0.283	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.717	0.283	0.000
E00 Congenital iodine-deficiency syndrome	0.717	0.283	0.000
E12 Malnutrition-related diabetes mellitus	0.717	0.283	0.000
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283	0.000
E03.5 Myxoedema coma	0.717	0.283	0.000
E03.4 Atrophy of thyroid (acquired)	0.717	0.283	0.000
E03.3 Postinfectious hypothyroidism	0.717	0.283	0.000
E03.1 Congenital hypothyroidism without goitre	0.717	0.283	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.717	0.283	0.000
H32 Chorioretinal disorders in diseases classified elsewhere	0.717	0.283	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.717	0.283	0.000
D82 Immunodeficiency associated with other major defects	0.717	0.283	0.000
D81 Combined immunodeficiencies	0.717	0.283	0.000
M35.9 Systemic involvement of connective tissue, unspecified	0.717	0.283	0.000
M35.8 Other specified systemic involvement of connective tissue	0.717	0.283	0.000
M35.6 Relapsing panniculitis [Weber-Christian]	0.717	0.283	0.000
M35.5 Multifocal fibrosclerosis	0.717	0.283	0.000
M35.4 Diffuse (eosinophilic) fasciitis	0.717	0.283	0.000
E15 Nondiabetic hypoglycaemic coma	0.717	0.283	0.000
E14.7 With multiple complications	0.717	0.283	0.000
E14.0 With coma	0.717	0.283	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.717	0.283	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.717	0.283	0.000
E16.4 Abnormal secretion of gastrin	0.717	0.283	0.000
E16.3 Increased secretion of glucagon	0.717	0.283	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.717	0.283	0.000
M18 Arthrosis of first carpometacarpal joint	0.717	0.283	0.000
K77 Liver disorders in diseases classified elsewhere	0.717	0.283	0.000
K71 Toxic liver disease	0.717	0.283	0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.716	0.283	0.000
A75-A79 Rickettsioses	0.716	0.283	0.000
A70-A74 Other diseases caused by chlamydiae	0.716	0.283	0.000
A20-A28 Certain zoonotic bacterial diseases	0.716	0.283	0.000
M36 Systemic disorders of connective tissue in diseases classified elsewhere	0.716	0.284	0.000
K75.2 Nonspecific reactive hepatitis	0.716	0.284	0.000
K75.1 Phlebitis of portal vein	0.716	0.284	0.000
I77.5 Necrosis of artery	0.716	0.284	0.000
I77.4 Coeliac artery compression syndrome	0.716	0.284	0.000
I77.3 Arterial fibromuscular dysplasia	0.716	0.284	0.000
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.716	0.284	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.716	0.284	0.000
I77.2 Rupture of artery	0.715	0.285	0.000
J43 Emphysema	0.715	0.285	0.000
G50 Disorders of trigeminal nerve	0.715	0.285	0.000
Y35-Y36 Legal intervention and operations of war	0.715	0.285	0.000
Y10-Y34 Event of undetermined intent	0.715	0.285	0.000
X85-X99 Assault	0.715	0.285	0.000
X30-X39 Exposure to forces of nature	0.715	0.285	0.000
W75-W84 Other accidental threats to breathing	0.715	0.285	0.000
W65-W74 Accidental drowning and submersion	0.715	0.285	0.000
V95-V97 Air and space transport accidents	0.715	0.285	0.000
V70-V79 Bus occupant injured in transport accident	0.715	0.285	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.715	0.285	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.715	0.285	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.715	0.285	0.000
D64.4 Congenital dyserythropoietic anaemia	0.714	0.286	0.000
D64.3 Other sideroblastic anaemias	0.714	0.286	0.000
D64.2 Secondary sideroblastic anaemia due to drugs and toxins	0.714	0.286	0.000
D64.1 Secondary sideroblastic anaemia due to disease	0.714	0.286	0.000
D64.0 Hereditary sideroblastic anaemia	0.714	0.286	0.000
N04.1 Focal and segmental glomerular lesions	0.714	0.286	0.000
D84 Other immunodeficiencies	0.714	0.286	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.713	0.287	0.000
C84.5 Other and unspecified T-cell lymphomas	0.713	0.287	0.000
C85.0 Lymphosarcoma	0.713	0.287	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.713	0.287	0.000
C94 Other leukaemias of specified cell type	0.713	0.287	0.000
C86 Other specified types of T/NK-cell lymphoma	0.713	0.287	0.000
M12 Other specific arthropathies	0.712	0.288	0.000
B48 Other mycoses, not elsewhere classified	0.712	0.288	0.000
B47 Mycetoma	0.712	0.288	0.000
B46 Zygomycosis	0.712	0.288	0.000
B45 Cryptococcosis	0.712	0.288	0.000
B43 Chromomycosis and phaeomycotic abscess	0.712	0.288	0.000
B42 Sporotrichosis	0.712	0.288	0.000
B41 Paracoccidioidomycosis	0.712	0.288	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations